C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention
- 1 November 2015
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 136 (5) , 894-898
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos populationMolecular Biology Reports, 2014
- The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican populationThrombosis Research, 2012
- Assessment of Platelet Function in Patients on Antiplatelet Therapy Undergoing Cardiac Surgery: A ReviewHeart, Lung and Circulation, 2012
- Metabolic activation of clopidogrel:in vitrodata provide conflicting evidence for the contributions of CYP2C19 and PON1Therapeutic Advances in Drug Safety, 2011
- Genetic Causes of Clopidogrel Nonresponsiveness: Which Ones Really Count?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010
- Antithrombotics in Acute Coronary Syndromes: Updates from the Past YearCurrent Treatment Options in Cardiovascular Medicine, 2010
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- Platelet hyperactivity in type 2 diabetes: role of antiplatelet agentsDiabetes & Vascular Disease Research, 2008
- Impact of P-glycoprotein on clopidogrel absorptionClinical Pharmacology & Therapeutics, 2006
- Individual variations of platelet inhibition after loading doses of clopidogrelJournal of Internal Medicine, 2002